Doron Leib Cohen - 18 Mar 2026 Form 3 Insider Report for Galmed Pharmaceuticals Ltd. (GLMD)

Role: Chief Financial Officer
Signature: /s/ Doron Cohen
Issuer symbol: GLMD
Transactions as of: 18 Mar 2026
Net transactions value: $0
Form type: 3
Filing time: 18 Mar 2026, 07:45:49 UTC
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Cohen Doron Leib	Chief Financial Officer	C/O MEITAR LAW OFFICES, 16 ABBA HILLEL SILVER RD., RAMAT GAN, ISRAEL	/s/ Doron Cohen	18 Mar 2026	0001973593

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	GLMD	Ordinary Shares						22,083	18 Mar 2026	Direct
holding	GLMD	Restricted Share Units						2,083	18 Mar 2026	Direct	F1
holding	GLMD	Restricted Share Units						23,333	18 Mar 2026	Direct	F2
holding	GLMD	Restricted Share Units						25,000	18 Mar 2026	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	GLMD	Options to Purchase Ordinary Shares							18 Mar 2026	Ordinary Shares	208	$68.40	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These restricted share units vest on August 7, 2026, subject to the Reporting Person's continued service.
F2	These restricted share units vest in four equal installments on each of May 12, 2026, November 12, 2026, May 12, 2027 and November 12, 2027, subject to the Reporting Person's continued service.
F3	These restricted share units vest in accordance with the following vesting schedule: 1/3 shall vest on August 26, 2026 and the remaining portion shall vest in four equal installments on each of February 26, 2027, August 26, 2027, February 26, 2028 and August 26, 2028, subject to the Reporting Person's continued service.